3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Carboplatin
16
Pemetrexed
15
Cisplatin
15
Erlotinib Hydrochloride
13
icotinib
8
Propofol
7
Gefitinib
7
Gemcitabine
6
Docetaxel
6
endostar protein
5
Saline Solution
5
Paclitaxel
5
Nivolumab
5
Endostatins
5
tislelizumab
4
lorlatinib
4
anlotinib
4
Vinorelbine
4
Sevoflurane
4
Drug Therapy
4
Afatinib
4
pembrolizumab
3
durvalumab
3
atezolizumab
3
Zoledronic Acid
3
Radiotherapy
3
Dexamethasone
3
Acetaminophen
3
trilaciclib
2
pegfilgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Patient-Specific Modeling
×
Thoracic
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn